CRISPR Therapeutics (CRSP) Insider Trading & Ownership $40.72 +0.34 (+0.84%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CRISPR Therapeutics (NASDAQ:CRSP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$13.34 M Get CRSP Insider Trade Alerts Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRSP Insider Buying and Selling by Quarter Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. CRISPR Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/2/2024Samarth KulkarniCEOSell15,000$55.10$826,500.00 11/11/2024Samarth KulkarniCEOSell30,000$55.62$1,668,600.00 10/14/2024James R KasingerGeneral CounselSell1,089$46.28$50,398.92 10/14/2024Samarth KulkarniCEOSell4,293$46.28$198,680.04 6/21/2024Julianne BrunoCOOSell3,366$56.09$188,798.94 4/15/2024Samarth KulkarniCEOSell19,582$59.91$1,173,157.62 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/15/2024Raju PrasadCFOSell3,524$72.69$256,159.56 3/15/2024Samarth KulkarniCEOSell20,000$72.48$1,449,600.00 3/11/2024James R KasingerGeneral CounselSell2,801$78.26$219,206.26 3/11/2024Samarth KulkarniCEOSell9,802$78.26$767,104.52 2/20/2024James R KasingerGeneral CounselSell1,913$79.67$152,408.71 2/20/2024Samarth KulkarniCEOSell6,370$79.67$507,497.90 2/15/2024Samarth KulkarniCEOSell20,000$80.36$1,607,200.00 1/29/2024Samarth KulkarniCEOSell50,000$60.51$3,025,500.00 1/16/2024Samarth KulkarniCEOSell20,000$62.50$1,250,000.00 (Data available from 1/1/2013 forward) CRSP Insider Trading Activity - Frequently Asked Questions Who is on CRISPR Therapeutics's Insider Roster? The list of insiders at CRISPR Therapeutics includes James R Kasinger, Julianne Bruno, Raju Prasad, and Samarth Kulkarni. Learn more on insiders at CRSP. What percentage of CRISPR Therapeutics stock is owned by insiders? 4.10% of CRISPR Therapeutics stock is owned by insiders. Learn more on CRSP's insider holdings. Which CRISPR Therapeutics insiders have been selling company stock? The following insiders have sold CRSP shares in the last 24 months: James R Kasinger ($422,013.89), Julianne Bruno ($188,798.94), Raju Prasad ($256,159.56), and Samarth Kulkarni ($19,990,340.08). How much insider selling is happening at CRISPR Therapeutics? Insiders have sold a total of 357,740 CRISPR Therapeutics shares in the last 24 months for a total of $20,857,312.47 sold. CRISPR Therapeutics Key ExecutivesDr. Rodger Novak M.D. (Age 55)Founder, Chairman & Pres Dr. Samarth Kulkarni (Age 43)CEO & Director Compensation: $1.18M3 recent tradesDr. Lawrence Otto Klein Ph.D. (Age 40)Chief Operating Officer Compensation: $675kMr. James R. Kasinger (Age 50)Gen. Counsel & Sec. Compensation: $648.93k1 recent tradesMr. Shaun FoyFounderDr. Emmanuelle Marie CharpentierCo-Founder & Scientific Advisory Board MemberDr. Craig C. Mello Ph.D.Scientific Founder & Advisory Board MemberDr. Chad Cowan Ph.D.Scientific FounderDr. Matthew Porteus M.D. (Age 56)Ph.D., Scientific Founder & Advisory Board Member Dr. Daniel G. Anderson Ph.D.Scientific Founder & Advisory Board Member More Insider Trading Tools from MarketBeat Related Companies Neurocrine Biosciences Insider Trades Bio-Techne Insider Trades Vaxcyte Insider Trades Exelixis Insider Trades Repligen Insider Trades Revolution Medicines Insider Trades Halozyme Therapeutics Insider Trades Krystal Biotech Insider Trades Arcellx Insider Trades ADMA Biologics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:CRSP) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredThis Warning flashed just before the dot-com bust and the Great DepressionA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISPR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRSP Stock Alerts